Baxter settles FDA warning letter over problems at 3 overseas plants

10/21/2011 | Reuters

Baxter International has settled an FDA warning letter it received in January over concerns that it violated good manufacturing practice standards and failed to file post-market reports at its two facilities in Puerto Rico. The company also resolved safety issues related to peritoneal dialysis solutions manufactured at its facility in Ireland.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC